These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
726 related items for PubMed ID: 18039681
1. Daily practice effectiveness of a step-down treatment in comparison with a tight step-up for early rheumatoid arthritis. Verschueren P, Esselens G, Westhovens R. Rheumatology (Oxford); 2008 Jan; 47(1):59-64. PubMed ID: 18039681 [Abstract] [Full Text] [Related]
2. Triple therapy in early active rheumatoid arthritis: a randomized, single-blind, controlled trial comparing step-up and parallel treatment strategies. Saunders SA, Capell HA, Stirling A, Vallance R, Kincaid W, McMahon AD, Porter DR. Arthritis Rheum; 2008 May; 58(5):1310-7. PubMed ID: 18438851 [Abstract] [Full Text] [Related]
3. Dose escalation of parenteral methotrexate in active rheumatoid arthritis that has been unresponsive to conventional doses of methotrexate: a randomized, controlled trial. Lambert CM, Sandhu S, Lochhead A, Hurst NP, McRorie E, Dhillon V. Arthritis Rheum; 2004 Feb; 50(2):364-71. PubMed ID: 14872477 [Abstract] [Full Text] [Related]
4. The good initial response to therapy with a combination of traditional disease-modifying antirheumatic drugs is sustained over time: the eleven-year results of the Finnish rheumatoid arthritis combination therapy trial. Rantalaiho V, Korpela M, Hannonen P, Kautiainen H, Järvenpää S, Leirisalo-Repo M, Hakala M, Puolakka K, Julkunen H, Luosujärvi R, Möttönen T, FIN-RACo Trial Group. Arthritis Rheum; 2009 May; 60(5):1222-31. PubMed ID: 19404945 [Abstract] [Full Text] [Related]
5. The methotrexate therapeutic response in rheumatoid arthritis. Ortendahl M, Holmes T, Schettler JD, Fries JF. J Rheumatol; 2002 Oct; 29(10):2084-91. PubMed ID: 12375316 [Abstract] [Full Text] [Related]
6. Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: a two-year randomized trial. Svensson B, Boonen A, Albertsson K, van der Heijde D, Keller C, Hafström I. Arthritis Rheum; 2005 Nov; 52(11):3360-70. PubMed ID: 16255010 [Abstract] [Full Text] [Related]
7. Tight control and intensified COBRA combination treatment in early rheumatoid arthritis: 90% remission in a pilot trial. van Tuyl LH, Lems WF, Voskuyl AE, Kerstens PJ, Garnero P, Dijkmans BA, Boers M. Ann Rheum Dis; 2008 Nov; 67(11):1574-7. PubMed ID: 18625629 [Abstract] [Full Text] [Related]
8. Longterm combination therapy of refractory and destructive rheumatoid arthritis with methotrexate (MTX) and intramuscular gold or other disease modifying antirheumatic drugs compared to MTX monotherapy. Rau R, Schleusser B, Herborn G, Karger T. J Rheumatol; 1998 Aug; 25(8):1485-92. PubMed ID: 9712088 [Abstract] [Full Text] [Related]
9. Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use. Proudman SM, Keen HI, Stamp LK, Lee AT, Goldblatt F, Ayres OC, Rischmueller M, James MJ, Hill CL, Caughey GE, Cleland LG. Semin Arthritis Rheum; 2007 Oct; 37(2):99-111. PubMed ID: 17391739 [Abstract] [Full Text] [Related]
10. Patterns of disease modifying antirheumatic drug use in a Spanish cohort of patients with rheumatoid arthritis. Gonzalez-Alvaro I, Carmona L, Balsa A, Sanmarti R, Belmonte MA, Tena X, EMECAR Study Group. J Rheumatol; 2003 Apr; 30(4):697-704. PubMed ID: 12672186 [Abstract] [Full Text] [Related]
11. Treatment of early seropositive rheumatoid arthritis: doxycycline plus methotrexate versus methotrexate alone. O'Dell JR, Elliott JR, Mallek JA, Mikuls TR, Weaver CA, Glickstein S, Blakely KM, Hausch R, Leff RD. Arthritis Rheum; 2006 Feb; 54(2):621-7. PubMed ID: 16447240 [Abstract] [Full Text] [Related]
12. Contemporary use of disease-modifying drugs in the management of patients with early rheumatoid arthritis in Norway. Nikolaisen C, Kvien TK, Mikkelsen K, Kaufmann C, Rødevand E, Nossent JC. Scand J Rheumatol; 2009 Feb; 38(4):240-5. PubMed ID: 19229766 [Abstract] [Full Text] [Related]
13. Real-world effectiveness of select biologic and DMARD monotherapy and combination therapy in the treatment of rheumatoid arthritis: results from the RADIUS observational registry. Weaver AL, Lautzenheiser RL, Schiff MH, Gibofsky A, Perruquet JL, Luetkemeyer J, Paulus HE, Xia HA, Leff JA, RADIUS Investigators. Curr Med Res Opin; 2006 Jan; 22(1):185-98. PubMed ID: 16393444 [Abstract] [Full Text] [Related]
14. Comparison of two schedules for administering oral low-dose methotrexate (weekly versus every-other-week) in patients with rheumatoid arthritis in remission: a twenty-four week, single blind, randomized study. Luis M, Pacheco-Tena C, Cazarín-Barrientos J, Lino-Pérez L, Goycochea MV, Vazquez-Mellado J, Burgos-Vargas R. Arthritis Rheum; 1999 Oct; 42(10):2160-5. PubMed ID: 10524688 [Abstract] [Full Text] [Related]
15. Efficacy of tacrolimus in rheumatoid arthritis patients who have been treated unsuccessfully with methotrexate: a six-month, double-blind, randomized, dose-ranging study. Furst DE, Saag K, Fleischmann MR, Sherrer Y, Block JA, Schnitzer T, Rutstein J, Baldassare A, Kaine J, Calabrese L, Dietz F, Sack M, Senter RG, Wiesenhutter C, Schiff M, Stein CM, Satoi Y, Matsumoto A, Caldwell J, Harris RE, Moreland LW, Hurd E, Yocum D, Stamler DA. Arthritis Rheum; 2002 Aug; 46(8):2020-8. PubMed ID: 12209503 [Abstract] [Full Text] [Related]
16. Is the disease course of rheumatoid arthritis becoming milder? Time trends since 1985 in an inception cohort of early rheumatoid arthritis. Welsing PM, Fransen J, van Riel PL. Arthritis Rheum; 2005 Sep; 52(9):2616-24. PubMed ID: 16142762 [Abstract] [Full Text] [Related]
17. Effectiveness of systematic monitoring of rheumatoid arthritis disease activity in daily practice: a multicentre, cluster randomised controlled trial. Fransen J, Moens HB, Speyer I, van Riel PL. Ann Rheum Dis; 2005 Sep; 64(9):1294-8. PubMed ID: 15829574 [Abstract] [Full Text] [Related]
18. Indirect and total costs of early rheumatoid arthritis: a randomized comparison of combined step-down prednisolone, methotrexate, and sulfasalazine with sulfasalazine alone. Korthals-de Bos I, Van Tulder M, Boers M, Verhoeven AC, Adèr HJ, Bibo J, Boonen A, Van Der Linden S. J Rheumatol; 2004 Sep; 31(9):1709-16. PubMed ID: 15338488 [Abstract] [Full Text] [Related]
19. [Comparison of efficacy and tolerability of triple combination therapy (methotrexate + sulfasalazine + hydroxychloroquine) with methotrexate monotherapy in patients with rheumatoid arthritis]. Gubar' EE, Bochkova AG, Bunchuk NV. Ter Arkh; 2008 Sep; 80(5):25-30. PubMed ID: 18590110 [Abstract] [Full Text] [Related]
20. Effect of anakinra on functional status in patients with active rheumatoid arthritis receiving concomitant therapy with traditional disease modifying antirheumatic drugs: evidence from the OMEGA Trial. Le Loët X, Nordström D, Rodriguez M, Rubbert A, Sarzi-Puttini P, Wouters JM, Woolley JM, Wright N, Lawrence C, Appleton B. J Rheumatol; 2008 Aug; 35(8):1538-44. PubMed ID: 18634163 [Abstract] [Full Text] [Related] Page: [Next] [New Search]